In this episode of the Queens of Quality podcast, we explore the importance of discussing failure alongside success in the pharmaceutical and biotech industries. With only a small percentage of drugs making it to clinical testing, failure is an integral part of the industry. We discuss the lengthy process of bringing a product to market, the challenges faced, and the significance of collaboration between academia and the industry. Join us as we delve into the complexities of drug development and the lessons learned from failures. Don't forget to subscribe, like, review, and share the podcast to help us continue the conversation.Tune in!During this episode, you will learn about;0:00:32 The Queens of Quality discuss the topic of failure0:02:05 From Bench to Bedside: Pharma Industry's Journey0:05:14 The Challenge of Identifying the Right Target0:07:57 Ensuring Support and Documentation for Clinical Phases0:10:10 Phase One Trials: High Failure Rate and Cost Implications0:12:05 Multiple Development Paths and the Importance of Phase Two0:14:22 Phase Three Trials: Expanding Patient Population and Clinical Programs0:15:52 The Final Stretch: Phase Three Programs0:16:19 The Reality: Fast-paced and Not Funny0:18:23 Long Timelines and Challenges in Clinical Trials0:20:35 Study Drug Adherence: A Critical Factor in Audits0:21:15 High Adherence Rate in Children's Oncology Study0:23:25 The Importance of Reinvestment and Balancing Product Pipeline0:25:31 Collaboration between academia and industry in pharmaceutical innovation0:28:02 Progress and success in the pharma and biotech industry0:31:16 Wrapping up the Queens of Quality Podcast            Love the show? Subscribe, Rate, Review, Like, and Share!Let’s Connect!Website: https://metisconsultingservices.com/LinkedIn: https://www.linkedin.com/company/metis-consulting-services/Email: info@metisconsultingservices.com